Vote Scores

Home / Companies / Consun Pharmaceutical Group Limited / 31 May 2024

Meeting · year to 30 June 202420 filers reporting

Consun Pharmaceutical Group Limited: meeting of 31 May 2024

Votes reported on Form N-PX, item by item

20 Form N-PX filers reported votes at the Consun Pharmaceutical Group Limited meeting of 31 May 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 42.9% of reported votes for; 20 filers withheld from or voted against at least one nominee.

56 vote records from 20 filers. 0 of the 20 filers that marked the item either way voted against management.

0.0% for10.0% against90.0% other0.0% against management20 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

28 vote records from 20 filers. 0 of the 20 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management20 filers100.0% for0.0% against0.0% against management35,795,928 reported shares
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

112 vote records from 20 filers. 0 of the 20 filers that marked the item either way voted against management.

15.0% for0.0% against85.0% other0.0% against management20 filers74.1% for25.9% against25.9% against management143,183,712 reported shares, counted once per item in this group
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

112 vote records from 20 filers. 16 of the 20 filers that marked the item either way voted against management.

20.0% for80.0% against80.0% against management20 filers65.1% for34.9% against34.9% against management143,183,712 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

56 vote records from 20 filers. 0 of the 20 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management20 filers100.0% for0.0% against0.0% against management71,591,856 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Auditor
VanguardSplit or no voteFor
BlackRock and iSharesSplit or no voteFor
FidelityAgainstFor
DimensionalSplit or no voteFor
State Street and SPDRSplit or no voteFor
American CenturyAgainstFor
Nuveen and TIAASplit or no voteFor
ThriventSplit or no voteFor
AllianceBernsteinSplit or no voteFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Consun Pharmaceutical Group Limited meeting?

20 Form N-PX filers reported votes at the meeting of 31 May 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Consun Pharmaceutical Group Limited on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Consun Pharmaceutical Group Limited

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Consun Pharmaceutical Group Limited with a meeting date within three days of 31 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.